A detailed history of Graham Capital Management, L.P. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 55,573 shares of RARE stock, worth $2.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
55,573
Previous 44,035 26.2%
Holding current value
$2.8 Million
Previous $2.06 Million 11.14%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$37.42 - $51.61 $431,751 - $595,476
11,538 Added 26.2%
55,573 $2.28 Million
Q1 2024

May 15, 2024

BUY
$43.02 - $53.69 $1.3 Million - $1.62 Million
30,175 Added 217.71%
44,035 $2.06 Million
Q4 2023

Feb 14, 2024

BUY
$31.73 - $49.19 $439,777 - $681,773
13,860 New
13,860 $662,000
Q3 2022

Nov 14, 2022

BUY
$39.96 - $66.14 $237,202 - $392,607
5,936 New
5,936 $245,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.53B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.